Skip to main content
Clinical Trials/NCT02380040
NCT02380040
Unknown
Not Applicable

Examination of Perfusion Index in Term and Preterm Newborns Through Plethismography

Shaare Zedek Medical Center1 site in 1 country100 target enrollmentMarch 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Patent Ductus Arteriosus
Sponsor
Shaare Zedek Medical Center
Enrollment
100
Locations
1
Primary Endpoint
Perfusion Index
Last Updated
9 years ago

Overview

Brief Summary

Photoplethismography will be measured and compared in newborns suffering from patent ductus arteriosus and normal controls.

Detailed Description

Newborn babies admitted to the NICU and well baby will be connected to a specially designed photoplethismograph (PPG). Right hand (pre ductal), and and one of the legs (postductal) values will be compared, based on the formula Delta amplitude of PPG / baseline absorption (perfusion index (PI)). Normal values will be defined in healthy term and preterm babies, and clinical conditions in which the PI is expected to change (Patent Ductus Artheriosus, Persistent pulmonary hypertension of the newborn)will be compared with these normal values.

Registry
clinicaltrials.gov
Start Date
March 2015
End Date
March 2017
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • PDA, PPHN and Normal babies who underwent echocardiography

Exclusion Criteria

  • Other cardiac diseases

Outcomes

Primary Outcomes

Perfusion Index

Time Frame: 5 minutes

Study Sites (1)

Loading locations...

Similar Trials